Scoda Tubes Q2 FY27: PAT falls 66% YoY to ₹4.8 Cr as capacity ramp-up costs bite margins
PAT -65.74% YoY · revenue +2.54% · margins compressing
₹148.95 Cr
+2.54% YoY
₹4.79 Cr
-65.74% YoY
3.17%
-6.2pp YoY
₹0.8
Scoda Tubes' standalone PAT for Q2 FY27 fell 65.7% year-on-year to ₹4.79 Cr (from ₹13.97 Cr) even as revenue from operations rose a modest 2.5% YoY to ₹148.95 Cr. Sequentially, revenue jumped 19.8% QoQ (from ₹124.35 Cr) but PAT still slipped 8.9% QoQ (from ₹5.25 Cr), confirming the YoY profit story — not the QoQ revenue pop — is what matters here. EPS came in at ₹0.80 against ₹2.42 a year ago and ₹0.88 last quarter. There were no exceptional items in either period, so the reported and adjusted YoY moves are the same.
Q2 FY-2027 vs prior quarters
The squeeze sits below the operating line. Operating margin (OPM) compressed to roughly 10.6% from 15.4% a year ago and about 12.9% last quarter, while net margin fell to 3.2% from 9.4% YoY. Depreciation nearly tripled YoY to ₹4.80 Cr (from ₹1.72 Cr) and finance costs rose 25.8% YoY to ₹6.93 Cr, as the company capitalises and debt-funds the new welded-tube capacity it has been building — capital work-in-progress rose to ₹45.39 Cr from ₹8.81 Cr at FY26-end, and non-current borrowings grew to ₹96.79 Cr from ₹44.06 Cr. Revenue growth has not yet caught up with these fixed costs.
The stock went into the print at ₹113, down 7.6% over the past month of trading.
What the summary numbers don't show
No consolidated results — the company has no subsidiary, JV or associate, so standalone is the sole and primary basis.
Scoda Tubes is projecting a robust 25% revenue growth in FY27, targeting 14% to 15% EBITDA margins. This growth is expected to be driven by the ramp-up of new capacities, particularly in the welded segment, which will also open new end-use sectors. The company anticipates a 40% export and 60% domestic revenue mix. Whil
— This quarter: missed
Against management's own FY27 guidance of 25% revenue growth and 14-15% EBITDA margins — repeated on the May 2026 concall, where the company called that target conservative and said it would revisit it in H1 FY27 — the actual H1 FY27 print (revenue up 12.6% YoY to ₹273.29 Cr, PAT down 52.3% YoY to ₹10.04 Cr) is running well short of both the growth pace and the margin band, a clear miss rather than the upgrade the prior call's confident tone implied. No formal Q2 FY27 street consensus could be confirmed this round — coverage of the stock is thin and recent brokerage reads found were inconsistent, so vs-street is left unresolved rather than guessed. No management press release accompanied this filing to cross-check against the numbers.
W1
Whether the new welded-tube facility, flagged for H2 FY27 commissioning, starts contributing volumes/revenue and lifts OPM back toward the guided 14-15% band.
W2
Whether management formally revises its 25% FY27 revenue growth guidance at the H1 review it flagged on the last call — H1 growth of 12.6% is tracking well below that pace.
W3
Trajectory of finance costs (₹6.93 Cr this quarter) and depreciation (₹4.80 Cr) as capex-funded borrowings (₹96.79 Cr non-current) and capitalised assets keep rising through H2.
Filing states figures in ₹ Millions; converted to Crore (÷10). No exceptional items in current or year-ago quarter. Company has no subsidiary/JV/associate (Note 5), so only standalone results exist — no consolidated statement applicable.
Flat quarter, margin collapse, guidance cut — ramp execution critical
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Guided 14-15% EBITDA margins; delivered 10.6%. Guided 25% FY27 growth; now saying 20-25% with Q2 only +2.5%, requiring 30%+ H2 growth.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Scoda's Q2 was a miss: revenue flat (+2.5% YoY), PAT collapsed 65.7%, EBITDA margins fell 479 bps below guidance. Management reaffirmed 20-25% FY27 growth and new welded capacity, but execution risk is high (project delays evident), margin recovery path is unclear, and guidance on profitability was withdrawn. Long-term capacity expansion has merit but near-term headwinds (weak domestic demand, intense competition, elevated costs) make near-term earnings trajectory uncertain.
₹148.9 Cr
Revenue · +2.5% YoY₹4.8 Cr
Reported PAT · −65.7% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Revenue remained largely flat YoY in Q2
METRevenue ₹148.9 Cr, +2.5% YoY vs ₹145.3 Cr Q2 FY26
Reaffirm 20-25% FY27 revenue growth confidence
OVERSTATEDQ2 flat (+2.5%), H1 at +12.6% YoY growth; H2 needs 30%+ to hit 20-25% FY target
EBITDA margin 10.6% reflects power/fuel cost pressure
METQ2 EBITDA margin 10.6% vs Q2 FY26 15.38% — a 479 bps collapse vs prior 14-15% guidance target
Order book ₹185 Cr provides visibility
MISS₹185 Cr order book all from seamless segment; no welded orders in book despite welded ramp starting Q4
Seamless capacity utilization targeting ~70% in FY27
UnverifiedManagement refrained from disclosing current utilization citing competitive reasons; claims 70% target but Q2 flat revenue
Earnings quality
What changed since the last call
EBITDA margin guidance withdrawn
WithdrawnPrior: 14-15% EBITDA margin target. This call: Refrain from guidance, focus on 'protecting profitability'. Delivered: 10.6% (479 bps below range).
Revenue guidance range narrowed with hedging
DowngradePrior: 25% growth. This call: 20-25% range, adding a 20% floor. Q2 delivered +2.5% YoY, requiring 30%+ H2 growth to hit even 20% FY target.
Capacity expansion timeline extended
DowngradeWelded project delay: Originally planned H1 commission now Q4 FY27 trial, H1 FY28 commercial ramp. Brownfield 8,000 MT adds execution risk.
Net debt rose to ₹100 Cr from ₹40 Cr
DowngradeDebt increased due to capex funding (₹45 Cr budgeted, remaining deferred). No immediate plans to reduce; peak debt expected ₹250 Cr (per management).
The Q&A
Analysts pressed hard on margin recovery (Aryan Bhatia), competitive moat under pressure (Rohit Suresh), and growth achievability with weak Q2 (Shreyans Jain). Management held firm on guidance but was defensive/evasive on specifics, esp. margins and capacity utilization. Confidence largely rested on order book and future capacity, not current execution.
Welded project delay — Aryan Bhatia, InVed
AnsweredGas supply disruptions in Mar-Apr caused construction delays 2-3 months. Trial production already underway Q4 FY27; commercial launch Jan FY27 with revenue benefit in H2.
EBITDA margin recovery — Aryan Bhatia, InVed
DodgedPremature to provide guidance. Cost optimization and operational efficiency underway. Priority is protecting EBITDA margins in Q2 FY27 while continuing focus on execution.
FY27 growth confidence — Shreyans Jain, 3A Capital
PartialRevenue growth driven by welded ramp (Q4 FY27 onwards), improved demand in H2, and volume ramp from 70% capacity utilization. H2 expected stronger than H1.
Order book execution timeline — Shreyans Jain, 3A Capital
AnsweredAlmost 40% exports, order book all seamless. Execution 4-5 months. Welded orders expected post-trial production in Q4.
Competitive capacity addition impact — Shreyans Jain, 3A Capital
PartialRevenue growth on volumes will be pressured; margins affected. Scoda's moat: specialized production, customer diversity, international approvals. Competition constrains pricing power, hence margins remain under pressure.
Sustainable moat claim — Rohit Suresh, Samatva Investments
PartialMoat is specialization (SS pipes), customer diversity, international presence, approvals. Not a short-term advantage but positions company well once capacity ramps. Rough patch last 10 years; bright future post-Jan/Feb.
Margins at peak capacity — Rohit Suresh, Samatva Investments
PartialSeamless gross margins 32-33%. Welded lower at around 25%. Specific guidance deferred due to geopolitical uncertainty.
Solar power cost savings — Aryan Bhatia, InVed
AnsweredSolar generation already live for seamless. Welded will benefit from solar starting Jan 2027 when production begins. Will help power cost per unit.
Seamless capacity utilization — Aryan Bhatia, InVed
DodgedCannot disclose due to competitive reasons. Targeting ~70% utilization for FY27.
Debt trajectory — Aryan Bhatia, InVed
AnsweredAdded 8,000 MT welded capacity + 9 MW solar via debt. Peak debt expected ₹250 Cr. No immediate plans to reduce; debt will come down post-capacity ramp and revenue growth materialization.
Capex spend and IRR — Bhavik Shah, Invexa MK Ventures
AnsweredTotal budgeted capex ₹45 Cr. ₹45 Cr for additional 8,000 MT welded. IRR target 15-20% (may vary due to geopolitical uncertainties). Remaining capex of ₹40-50 Cr for 12,000 MT will be in FY28.
Working capital & cash flow — Sai Kiran, Family Office
AnsweredInventory elevated due to production buildup + slower conversion. Expect normalization in H2 with improved sales conversion and inventory turnover reduction.
Domestic segment weakness — Hemkesh Khattar, Green Portfolio
AnsweredOil & gas sector running low; power sector good, awaiting BHEL/NTPC tender awards. Domestic order book ₹180 Cr, mostly power/chemical. Recovery dependent on BHEL tender and demand normalization.
Fuel cost normalization & margins — Randeep, Investure Capital
DodgedGas costs still high; refrain from margin guidance. Revisit in H2. Competition also limits ability to pass costs through price hikes.
Europe quota system impact — Rohit Suresh, Samatva Investments
AnsweredYes, imports reducing from China. Customers now must buy locally or pay higher duties. This helps Scoda's export pricing but not immediate given customer warehousing inventory.
Welded revenue potential — Randeep, Investure Capital
DodgedNot sharing FY28+ numbers until welded production starts in Jan. After that can comment on full year potential.
Guidance
FY27 revenue growth 20-25%
MediumDriven by welded ramp Q4 FY27 onwards + H2 demand recovery. Q2 flat (+2.5%) requires H2 growth 30%+ to hit 20% floor; 35%+ for 25% target. Achievability hinges on welded commercial success and order execution.
H2 FY27 expected to deliver 'strong revenue growth'
MediumManagement verbal claim. Order book ₹185 Cr provides baseline. Welded trial expected to generate orders in Q3-Q4 for H2 execution.
No specific EBITDA margin target provided
LowPrior: 14-15%. Management refrained, citing geopolitical uncertainty. Focus stated as 'protecting existing profitability' and 'operational efficiencies.' Implies management sees margin recovery as uncertain/slow.
Total capex budget ₹45 Cr (welded 20K MT + solar)
High₹45 Cr already committed for 8,000 MT welded + solar. Remaining ₹40-50 Cr for 12,000 MT brownfield deferred to FY28. Civil construction on track, equipment procurement on track.
Risks the call surfaced
Execution risk — capacity ramp
HighWelded facility already delayed 2-3 months (civil/labour disruptions). Trial production Q4 FY27, commercial Jan 2027. Brownfield 8,000 MT capex execution also at risk given delays to date.
Margin pressure — structural
HighPower costs +190 bps, freight +150 bps, competition +130 bps YoY. Management refrained from margin guidance, signalling low confidence in recovery. Gross margins welded 25% vs seamless 32-33%.
Demand risk — domestic segment
HighDomestic revenue down 12% YoY; oil/gas sector weak. Only power and chemical sectors showing strength. BHEL/NTPC tender awards uncertain timing; critical for domestic order pipeline.
Competitive intensity — capacity oversupply
HighIndustry added 60-70K tons new seamless capacity. All additions from private players. Pricing power constrained; Scoda unable to pass higher input costs through price hikes. Revenue growth may require volume gains at margin sacrifice.
Financial leverage — debt rising
MediumNet debt ₹100 Cr (vs ₹40 Cr prior). Peak debt ₹250 Cr expected as capex continues. PAT down 65.7% YoY; declining profitability coupled with rising debt increases financial stress.
Working capital deterioration
MediumInventory days increased due to elevated production levels and slower sales conversion (competitive pressures). Working capital cycle worsened; ~70% of cash stuck in working capital per analyst commentary.
Management
Score 5/10. Candid on challenges (cost inflation, competition, margin pressure) but evasive on recovery timeline and margin targets. Refused to quantify EBITDA recovery path. Mixed: Solar power on track, RINA Marine audit complete, but welded project delayed 2-3 months. Revenue flat Q2 despite ₹185 Cr order book suggests execution drag.
1 · Q4 FY27 (Jan-Mar 2027)
Welded trial production, data center / HVAC sector inquiries to orders
2 · Q1 FY28 (Apr-Jun 2027)
Brownfield welded capacity 8,000 MT commercial ramp; RINA marine orders execution
3 · H1 FY28
Total welded capacity 21,150 MT commissioned; expected to drive revenue/margin recovery
Long-term capacity expansion has merit but near-term headwinds (weak domestic demand, intense competition, elevated costs) make near-term earnings trajectory uncertain.
Flat Revenue, Margin Collapse, Guidance Cut — Execution Risk Now Critical
Scoda guided 25% FY27 revenue growth and 14–15% EBITDA margins. Q2 delivered flat revenue (+2.5%), margins crushed to 10.6% (479 bps below guidance), and PAT down 65.7%. Management has now hedged guidance, withdrawn margin targets, and delayed the welded ramp that was supposed to drive recovery.
₹148.9 Cr
+2.5% YoY
₹4.8 Cr
−65.7% YoY
10.6%
−479 bps vs FY26 | −479 bps vs guidance
₹185 Cr
4–5 month execution window
On paper, Scoda's Q2 delivered stable revenue (+2.5% YoY) and a comforting order book of ₹185 crore. But beneath the headline sits the real quarter: PAT down nearly 66%, EBITDA margins at their lowest in recent memory, and management's explicit abandonment of margin targets. This is not a soft quarter. This is a warning.
Guidance vs. reality: where the credibility cracked
In prior calls, Scoda promised 25% FY27 revenue growth and 14–15% EBITDA margins. Six months in, the company is delivering neither. Q2 revenue grew just 2.5% YoY. H1 (two quarters in) reached 12.6% YoY growth. To hit even the newly hedged floor of 20% FY27 growth, Scoda needs H2 to grow 30% or faster—a leap management has not articulated a credible path to achieve.
Revenue remained largely flat YoY
₹148.9 Cr, +2.5% YoY vs ₹145.3 Cr Q2 FY26
Supported
Reaffirm 20–25% FY27 revenue growth confidence
Q2 +2.5%, H1 +12.6%; H2 needs 30%+ to hit 20% floor
Overstated
EBITDA margin 10.6% reflects power/fuel cost pressure
10.6% vs 15.38% Q2 FY26; vs 14–15% prior guidance
Supported (but magnitude was hidden)
Order book ₹185 Cr provides visibility
All seamless; no welded orders despite welded ramp starting Q4
Contradicted
Seamless capacity utilization targeting ~70%
Management refused to disclose actual utilization
Unverified
What changed on this call
EBITDA margin guidance withdrawn (was 14–15%, now refused)
Revenue guidance narrowed and hedged (was 25%, now 20–25%)
Welded project delayed 2–3 months; trial now Q4 FY27, commercial Jan 2027
Net debt doubled to ₹100 Cr from ₹40 Cr; peak expected ₹250 Cr
PAT margin collapsed to 3.2% from 9.5% YoY
Every major metric moved in the wrong direction. The withdrawal of margin guidance is the tell—when management removes a target, it signals internal conviction has cracked. Scoda no longer believes in a near-term margin recovery path, and refused to quantify one under analyst pressure.
The bull case and the bear case
The honest read: Scoda has a defensible long-term story, but near-term credibility is shot. Management has explicitly wavered on margin recovery and hedged on growth—that matters more than the welded thesis. For a holder today, the binary is unforgiving: either H2 delivers 30%+ growth AND management re-guides on margins, or the stock reprices lower. The market is clearly betting the latter.
The bull-bear ledger
₹185 Cr order book; 4–5 month execution horizon provides near-term revenue certainty
Welded and new verticals (data centers, HVAC, marine) address structural market shifts
4.99 MW solar; cost tailwind for welded ops starting Jan 2027
RINA Marine audit complete; European marine orders pipeline opens
Revenue flat despite ₹185 Cr order book—execution drag or inventory buildup?
EBITDA margin guidance withdrawn—management sees no clear path to recovery
Welded delayed 2–3 months; brownfield capex also at execution risk
Domestic segment weak (oil/gas −12%); power tenders timing uncertain
Industry capacity additions 60–70K tons; pricing power constrained
Net debt ₹100 Cr, peak ₹250 Cr; declining profit hampers repayment
Risks, ranked by how much they should concern a holder
Execution risk on welded capacity ramp
HIGHWelded project already delayed 2–3 months (civil/labour disruptions). Trial production Q4 FY27, commercial launch Jan 2027. Brownfield 8,000 MT capex also at risk. If welded misses, FY27 revenue growth target is impossible.
Margin recovery path opaque
HIGHManagement explicitly withdrew EBITDA margin targets (was 14–15%). Under analyst pressure, refused to quantify recovery. Power costs still high; competition limits pass-through. No credible path to prior guidance.
Domestic segment weakness
HIGHOil & gas sector running low; domestic revenue down 12% YoY. Power sector strong but dependent on BHEL/NTPC tender awards—timing uncertain. 63% of revenue is domestic; weakness cascades.
Competitive capacity oversupply
HIGHIndustry added 60–70K tons new seamless capacity. All from private players. Pricing power constrained; Scoda's 20K MT capacity now smaller relative to industry. Revenue growth may require volume gains at margin sacrifice.
Rising debt amid PAT collapse
MEDIUMNet debt ₹100 Cr (vs ₹40 Cr prior); peak ₹250 Cr expected. PAT down 65.7% YoY; profit pool shrinking while debt rises. Debt repayment hinges on growth realization—if that slips, leverage becomes dangerous.
Working capital deterioration
MEDIUMInventory buildup (production elevated for demand that didn't materialize); cash conversion slowed due to competitive pressures. ~70% of cash stuck in working capital. Normalization expected H2 but if demand remains soft, WC drag persists.
How the street is positioned
The stock sits at ₹102.34, trading 55% below its all-time high of ₹230.85. Over the past 52 weeks, it has range-bound between ₹101.5 and ₹181.48—and it is now near the lows. Trading below its 20-day, 50-day, and 200-day moving averages (at ₹108.68, ₹119.9, and ₹133.45 respectively), the price action is decisively bearish. RSI at 33.6 suggests neutral momentum (not oversold enough yet to trigger a technical bounce).
Volume is increasing on the way down—a distribution signal. Institutions are selling. FII ownership is steady at 8.58% (up 20 bps from Q1), but DII ownership has collapsed to 0.44% from 3.58% in Q1—a sharp 314 bps exit by domestic institutions. This is a caution signal: the DII (often viewed as informed sellers) is trimming.
Bulk dealing data adds color. On May 27, HUTOXY KERSI BHADHA sold 3.08 lakh shares at ₹127.77 per share. On May 8, MNCL CAPITAL COMPOUNDER FUND sold 5 lakh shares at ₹157.56. Both transactions occurred at prices near the 52-week highs—informed sellers, likely sophisticated investors, reducing exposure before the weakness became apparent.
The combined picture is clear: the stock has re-rated lower in line with a credibility loss. The 55% drawdown from ATH is not overdone given the fundamentals—execution risk is real, margins are under pressure, and management has lost conviction. For a speculative entry (betting on H2 execution and margin recovery), the price may offer opportunity. But for a holder, the technical picture and institutional flow suggest the re-rating may not be finished.
What to watch next—the resolve
1 · H2 FY27 revenue growth trajectory
The make-or-break metric. Scoda needs 30%+ H2 growth to hit even the 20% FY floor. If H2 revenue growth lands below 15%, the bear case wins and further downside is likely. Track Q3 results (expected Jan 2027) as the first read.
2 · Welded trial production and commercial ramp success
Trial production expected Q4 FY27; commercial launch Jan 2027. Any further delays or production issues invalidate the long-term thesis. Listen for updates in the Q3 call (Jan 2027) on trial progress and commercial readiness.
3 · Domestic demand stabilization and BHEL/NTPC tender awards
Oil & gas is weak; power is the lone bright spot. BHEL and NTPC tender awards will determine whether domestic revenue can recover from −12% YoY. If these awards are delayed or won by competitors, domestic recovery is derailed and FY27 growth is at risk.
4 · Management commentary on EBITDA margin recovery
The next earnings call (Q3 FY27, expected Jan 2027) will be the test. Does management re-guide on margins (even cautiously) or continue to hedge? A re-guidance would signal returning conviction; further hedging would validate the bear case.
Scoda Tubes has a long-term thesis—welded capacity ramp, new verticals, cost tailwinds—but near-term credibility is in tatters. Flat Q2 revenue, margin collapse, guidance withdrawal, and execution delays have shattered management's narrative. The market's repricing (55% from ATH) reflects justified skepticism.
This is not a valuation story anymore. It's an execution story. For a holder, the binary is unforgiving: either H2 delivers a growth rate above 15% AND management re-guides on margins, or the stock reprices lower. The street has clearly chosen to bet against near-term execution. Until proven wrong, that read likely holds.
The single metric to track: H2 revenue growth rate. Below 15%, the bear case is validated. Above 20%, credibility begins to return. Anything in between is a coin flip with execution risk tilted to the downside.